Description
Tirzepatide 10mg is a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It combines the activity of two incretin pathways in a single molecule.
Tirzepatide has been developed for the management of type 2 diabetes and chronic weight management in approved clinical settings. Its mechanism supports glucose-dependent insulin secretion, helps regulate glucagon activity and may reduce appetite by promoting a longer-lasting feeling of satiety.
Clinical studies have demonstrated significant improvements in glycaemic control and body-weight reduction when tirzepatide is used under appropriate medical supervision.
This product should be handled and stored in accordance with the information provided on the packaging. Use only under the guidance of a qualified healthcare professional.
